The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Disc Medicine, Inc. COM 254604101   14,065,311 243,513 SH   SOLE   243,513 0 0
Hims & Hers Health, Inc. COM CL A 433000106   34,117,091 3,833,381 SH   SOLE   3,833,381 0 0
Kinnate Biopharma Inc. COM 49705R105   8,356,518 3,525,957 SH   SOLE   3,525,957 0 0
Theseus Pharmaceuticals, Inc. COM 88369M101   16,640,624 4,108,796 SH   SOLE   4,108,796 0 0
23andMe Holding Co. CLASS A COM 90138Q108   212,115 232,200 SH   SOLE   232,200 0 0